Results
3042
Most Popular Stocks on the market
3042 companies
NextCell Pharma
Market Cap: SEK 107.5m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 0.96
7D
-3.3%
1Y
-42.2%
Marker Therapeutics
Market Cap: US$11.4m
A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR
US$0.95
7D
0%
1Y
-67.2%
HOOKIPA Pharma
Market Cap: US$11.3m
A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.
HOOK
US$0.93
7D
0.4%
1Y
-78.1%
Ghani Global Glass
Market Cap: PK₨3.2b
Engages in the manufacture and sale of glass tubes, glass wares, vials, ampules, and chemicals in Pakistan and Egypt.
GGGL
PK₨13.23
7D
1.2%
1Y
124.2%
Carisma Therapeutics
Market Cap: US$11.2m
A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.
CARM
US$0.29
7D
15.9%
1Y
-71.3%
Tissue Repair
Market Cap: AU$17.2m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.28
7D
3.6%
1Y
-20.8%
Nanologica
Market Cap: SEK 105.6m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 1.20
7D
1.7%
1Y
-48.0%
Artelo Biosciences
Market Cap: US$11.2m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$5.51
7D
-2.0%
1Y
-15.7%
DIOD Maker of Eco-Friendly Equipment and Nutrition
Market Cap: ₽677.1m
DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company researches, develops, manufactures, and sells nutritional supplements, pharmaceuticals, active cosmetics, and health equipment for home use.
DIOD
₽7.40
7D
0%
1Y
-13.5%
Zenith Capital
Market Cap: US$11.2m
A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.
ZHCL.F
US$0.10
7D
42.9%
1Y
0%
Pharmesis International
Market Cap: S$14.4m
An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.
BFK
S$0.46
7D
0%
1Y
261.1%
TME Pharma
Market Cap: €9.5m
A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.
ALTME
€0.10
7D
9.0%
1Y
-25.0%
Abera Bioscience
Market Cap: SEK 104.4m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 6.80
7D
-12.8%
1Y
70.0%
Quantumzyme
Market Cap: US$11.1m
Operates as a biotransformation company.
QTZM
US$0.28
7D
-2.6%
1Y
n/a
Mercury Laboratories
Market Cap: ₹982.3m
Engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally.
538964
₹818.55
7D
-2.7%
1Y
-19.8%
Cytophage Technologies
Market Cap: CA$15.4m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.24
7D
-2.0%
1Y
-2.0%
Sensei Biotherapeutics
Market Cap: US$11.1m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$8.80
7D
-2.2%
1Y
-20.8%
XTL Biopharmaceuticals
Market Cap: ₪37.0m
A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.
XTLB
₪0.042
7D
2.4%
1Y
-55.3%
Althea Group Holdings
Market Cap: AU$16.9m
Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.
AGH
AU$0.02
7D
0%
1Y
-45.9%
PhoenixBio
Market Cap: JP¥1.6b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥407.00
7D
-1.9%
1Y
-8.1%
Eco-Growth Strategies
Market Cap: US$10.8m
Falcon Technologies, Inc. provides various design-build infrastructure services.
ECGS
US$0.20
7D
-2.5%
1Y
84.3%
Cardiogeni
Market Cap: UK£8.0m
A clinical stage biotechnology company, develops heart failure medicines.
CGNI
UK£0.09
7D
0%
1Y
n/a
Mediplantex National Pharmaceutical
Market Cap: ₫282.9b
Produces and trades in pharmaceutical products in Vietnam and internationally.
MED
₫22,800.00
7D
0%
1Y
-12.3%
Sharp Therapeutics
Market Cap: CA$15.0m
A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.
SHRX
CA$0.50
7D
0%
1Y
n/a
4SC
Market Cap: €9.2m
A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany and internationally.
VSC
€0.84
7D
-17.5%
1Y
-84.2%
Bolt Biotherapeutics
Market Cap: US$10.6m
A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.
BOLT
US$5.42
7D
3.6%
1Y
-56.3%
Bio Green Med Solution
Market Cap: US$10.6m
Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.
BGMS
US$5.15
7D
10.8%
1Y
-97.9%
Union Korea Pharm
Market Cap: ₩15.4b
Engages in the research, development, production, and sale of prescription drugs in South Korea.
A080720
₩2,725.00
7D
0%
1Y
-45.2%
Lyra Therapeutics
Market Cap: US$10.5m
A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.
LYRA
US$6.47
7D
1.9%
1Y
-51.3%
Evoke Pharma
Market Cap: US$10.5m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$4.90
7D
-6.1%
1Y
1.9%
Matinas BioPharma Holdings
Market Cap: US$10.4m
A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.
MTNB
US$1.90
7D
8.6%
1Y
-46.8%
Genomed Spólka Akcyjna
Market Cap: zł38.1m
Provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland.
GEN
zł28.80
7D
5.1%
1Y
4.3%
PExA
Market Cap: €8.9m
Develops and commercializes diagnostic products in various respiratory diseases.
FA0
€0.011
7D
-8.0%
1Y
-59.8%
Ludwig Enterprises
Market Cap: US$10.3m
Operates as a genomic technology and health related company in the United States.
LUDG
US$0.064
7D
-8.4%
1Y
-74.4%
Bharat Immunologicals & Biologicals
Market Cap: ₹914.1m
A biotechnology company, engages in the manufacture and sale of pharmaceutical products in India.
524663
₹21.17
7D
-3.5%
1Y
-28.4%
Firebrick Pharma
Market Cap: AU$15.7m
Engages in the development and commercializing of formulations for the uses of povidone iodine in Australia, the United states and Singapore.
FRE
AU$0.063
7D
-3.1%
1Y
5.0%